An interdisciplinary study correlates diabetic markers and psychological variables, concluding that self-efficacy, understood as the belief in one's ability to achieve results, generates changes in behavior that improve glycemic control among adolescent patients with type I diabetes

Dr. Nora Volkow, Director of the National Institutes of Health’s National Institute on Drug Abuse (NIDA), discusses her groundbreaking work in addiction neuroscience and brain imaging in a comprehensive Genomic Press Interview. Dr. Volkow reveals how personal experiences shaped her mission to destigmatize addiction and advance evidence-based treatments, while exploring promising developments in treatment and recovery.